Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 38.80
+1.20 (3.19%)
At close: Mar 26, 2026
Easywell Biomedicals Revenue
In the year 2025, Easywell Biomedicals had annual revenue of 597.41M TWD with 10.54% growth. Easywell Biomedicals had revenue of 162.19M in the quarter ending December 31, 2025, with 5.54% growth.
Revenue
597.41M
Revenue Growth
+10.54%
P/S Ratio
8.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 597.41M | 56.97M | 10.54% |
| Dec 31, 2024 | 540.44M | 268.81M | 98.96% |
| Dec 31, 2023 | 271.63M | 92.73M | 51.83% |
| Dec 31, 2022 | 178.90M | -18.38M | -9.32% |
| Dec 31, 2021 | 197.28M | -70.38M | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Formosa Laboratories | 4.85B |
| Orient EuroPharma | 4.60B |
| Handa Pharmaceuticals | 1.62B |
| Maywufa Company | 1.58B |
| Orient Pharma | 1.40B |
| SCI Pharmtech | 1.34B |
| Allied Biotech | 849.51M |
| Johnson Chemical Pharmaceutical Works | 569.77M |